Sphingosin-1-Phosphat-Rezeptor-Modulatoren bei Colitis ulcerosa – Game Changer oder einer unter vielen?Modulateurs du récepteur de la sphingosine-1-phosphate de la Colite ulcéreuse – Game Changer ou un parmi tant dʼautresModulatori del recettore della sfingosina-1-fosfato nella colite ulcerosa: game changer o uno tra i tanti

被引：0

作者：

Benjamin Misselwitz

Jon-Duri Senn

机构：

[1] Universitätsklinik für Viszerale Chirurgie und Medizin,Inselspital Bern, Bauchzentrum

来源：

Schweizer Gastroenterologie | 2022年 / 3卷 / 4期

关键词：

D O I：

10.1007/s43472-022-00087-x

中图分类号：

学科分类号：

摘要：

引用

页码：161 / 164

页数：3

共 8 条

[1]

Aoki M(2016)Sphingosine-1-phosphate signaling in immune cells and inflammation: roles and therapeutic potential Mediators Inflamm 2016 8606878-171

[2]

Karuppuchamy T(2017)Sphingosine-1-phosphate receptor-1 (S1P1) is expressed by lymphocytes, dendritic cells, and endothelium and modulated during inflammatory bowel disease Mucosal Immunol 10 162-413

[3]

Rubin DT(2019)ACG clinical guideline: ulcerative colitis in adults Am J Gastroenterol 114 384-265.e1–3

[4]

Sandborn WJ(2012)Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis Gastroenterology 142 257-710

[5]

Feagan BG(2013)Vedolizumab as induction and maintenance therapy for ulcerative colitis N Engl J Med 369 699-1736

[6]

Sandborn WJ(2017)Tofacitinib as induction and maintenance therapy for ulcerative colitis N Engl J Med 376 1723-1214

[7]

Sands BE(2019)Ustekinumab as induction and maintenance therapy for ulcerative colitis N Engl J Med 381 1201-e1821

[8]

Berger JR(2018)Progressive multifocal leukoencephalopathy after fingolimod treatment Neurology 90 e1815-undefined

← 1 →